The essentiality of Bcl-2, PKC and proteasome–ubiquitin complex activations in the neuroprotective-antiapoptotic action of the anti-Parkinson drug, rasagiline
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Biochemistry
Reference46 articles.
1. Mandel S, Weinreb O, Youdim MBH. Using cDNA microarray to assess Parkinson’s disease models and the effects of neuroprotective drugs. Trends Pharmacol Sci 2003.
2. Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B;Youdim;Br. J. Pharmacol.,2001
3. Tyramine antagonistic properties of AGN 1135, an irreversible inhibitor of monoamine oxidase type B;Finberg;Br. J. Pharmacol.,1981
4. Pharmacological properties of the anti-Parkinson drug rasagiline modification of endogenous brain amines, reserpine reversal, serotonergic and dopaminergic behaviours;Finberg;Neuropharmacology,2002
5. Rat striatal monoamine oxidases inhibition by I-deprenyl and rasagiline: its relationship to 2-phenylethylamine induced stereotypy and Parkinson’s disease;Youdim;Parkinsonism Relat. Disord.,2002
Cited by 73 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Mitochondria: A Promising Convergent Target for the Treatment of Amyotrophic Lateral Sclerosis;Cells;2024-01-29
2. 1,3-Bis(((E)-(9-ethyl-9H-carbazol-3-yl)methylene)amino)propan-2-ol: Synthesis, Characterization DFT Study, and Acetylcholinesterase Inhibitory Activity;Russian Journal of Physical Chemistry A;2023-05
3. Silibinin chronic treatment in a rat model of Parkinson disease: A comprehensive in-vivo evaluation and in silico molecular modeling;European Journal of Pharmacology;2023-02
4. FRET-Based Screening Identifies p38 MAPK and PKC Inhibition as Targets for Prevention of Seeded α-Synuclein Aggregation;Neurotherapeutics;2021-07
5. FRET-based screening in HEK293T identifies p38 MAPK and PKC inhibition as therapeutic targets for α-synuclein aggregation;2021-02-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3